Cor Vasa 2025, 67(4):483-492 | DOI: 10.33678/cor.2025.066

(Vasospastic angina pectoris - current diagnostic possibilities and management of patients)

Hana Moravcováa, Petr Kalab, Veronika Gašpárkováb, Petr Hájekb, Michal Rezekc, Ota Hlinomaza
a I. interní kardioangiologická klinika, Mezinárodní centrum klinického výzkumu (ICRC), Lékařská fakulta Masarykovy univerzity v Brně a Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika
b Kardiologická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha, Česká republika
c I. interní kardioangiologická klinika, Mezinárodní centrum klinického výzkumu (ICRC), Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika

Angina with non-obstructive coronary artery disease is a frequent finding in patients with chest pain. Its pathophysiology involves two main mechanisms: structural and functional dysfunction of microcirculation, functional dysfunction of epicardial arteries, and their combination. The review article focuses on diagnosis of vasospastic angina and management of patients with this disease.

Keywords: Acetylcholine testing, Angina with non-obstructive coronary artery disease (ANOCA), Epicardial vasospasm, Microvascular vasospasm, Vasospastic angina pectoris,

Received: February 28, 2025; Revised: May 15, 2025; Accepted: May 23, 2025; Prepublished online: June 2, 2012; Published: October 6, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Moravcová H, Kala P, Gašpárková V, Hájek P, Rezek M, Hlinomaz O. (Vasospastic angina pectoris - current diagnostic possibilities and management of patients). Cor Vasa. 2025;67(4):483-492. doi: 10.33678/cor.2025.066.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gulati M, Khan N, George M, et al. Ischemia with no obstructive coronary artery disease (INOCA): A patient self- -report quality of life survey from INOCA international. Int J Cardiol 2023;371:28-39. Go to original source... Go to PubMed...
    2. Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 2024;45:3415-3537. Go to original source... Go to PubMed...
    3. Ford TJ, Stanley B, Good R, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina. J Am Coll Cardiol 2018;72:2841-2855. Go to original source...
    4. Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020;41:3504-3520. Go to original source... Go to PubMed...
    5. Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus 2020;12:e9349. Go to original source... Go to PubMed...
    6. Jespersen L, Hvelplund A, Abildstrom SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012;33:734-744. Go to original source... Go to PubMed...
    7. Prinzmetal M, Goldman A, Shubin H, et al. Angina pectoris. II. Observations on the classic form of angina pectoris (preliminary report). Am Heart J 1959;57:530-543. Go to original source... Go to PubMed...
    8. Cheng TO, Bashour T, Kelser GA, et al. Variant Angina of Prinzmetal with Normal Coronary Arteriograms: A Variant of the Variant. Circulation 1973;47:476-485. Go to original source... Go to PubMed...
    9. Sueda S, Kohno H, Ochi T, et al. Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine. J Cardiol 2017;69:57-65. Go to original source... Go to PubMed...
    10. Beltrame JF. Management of vasospastic angina. Heart 2023;109:70-77. Go to original source... Go to PubMed...
    11. He Z, Xu X, Zhao Q, et al. Vasospastic angina: Past, present, and future. Pharmacol Ther 2023;249:108500. Go to original source... Go to PubMed...
    12. Mileva N, Nagumo S, Mizukami T, et al. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc 2022;11:e023207. Go to original source... Go to PubMed...
    13. Ong P, Athanasiadis A, Borgulya G, et al. High Prevalence of a Pathological Response to Acetylcholine Testing in Patients With Stable Angina Pectoris and Unobstructed Coronary Arteries. J Am Coll Cardiol 2012;59:655-662. Go to original source... Go to PubMed...
    14. Lanza GA, Crea F. Vasospastic angina. An article from the e-journal of the ESC Council for Cardiology Practice 2003(2):N°9-11 Nov 2003.
    15. Picard F, Sayah N, Spagnoli V, et al. Vasospastic angina: A literature review of current evidence. Arch Cardiovasc Dis 2019;112:44-55. Go to original source... Go to PubMed...
    16. Hung MJ, Cherng WJ, Cheng CW, Li LF. Comparison of Serum Levels of Inflammatory Markers in Patients With Coronary Vasospasm Without Significant Fixed Coronary Artery Disease Versus Patients With Stable Angina Pectoris and Acute Coronary Syndromes With Significant Fixed Coronary Artery Disease. Am J Cardiol 2006;97:1429-1434. Go to original source... Go to PubMed...
    17. Ohyama K, Matsumoto Y, Takanami K, et al. Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina. J Am Coll Cardiol 2018;71:414-425. Go to original source... Go to PubMed...
    18. Beltrame JF, Crea F, Kaski JC, et al. The Who, What, Why, When, How and Where of Vasospastic Angina. Circ J 2016;80:289-298. Go to original source...
    19. Rodríguez-Mañero M, Oloriz T, Le Polain De Waroux JB, et al. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm. Europace 2018;20:851-858. Go to original source... Go to PubMed...
    20. Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017;38:2565-2568.
    21. Montone RM, Rinaldi R, Del Buono MG, et al. Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries. EuroIntervention 2022;18:e666-e676. Go to original source... Go to PubMed...
    22. Aschermann M, Bultas J, Karetová D, et al. Randomized double-blind comparison of isosorbide dinitrate and nifedipine in variant angina pectoris. Am J Cardiol 1990;65:J46-J49. Go to original source... Go to PubMed...
    23. Beltrame JF, Tavella R, Jones D, Zeitz C. Management of ischaemia with non-obstructive coronary arteries (INOCA). BMJ 2021;375:e060602. Go to original source... Go to PubMed...
    24. Shin ES, Lee JH, Yoo SY, et al. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. Heart 2014;100:1531-1536. Go to original source... Go to PubMed...
    25. Jenkins K, Pompei G, Ganzorig N, et all. Vasospastic angina: a review on diagnostic approach and management. Ther Adv Cardiovasc Dis 2024;18:17539447241230400. Go to original source...
    26. Chahine RA, Feldman RL, Giles TD, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993;21:1365-1370. Go to original source...
    27. Lanza GA, Shimokawa H. Management of Coronary Artery Spasm. Eur Cardiol 2023;18:e38. Go to original source... Go to PubMed...
    28. Kim CH, Park TK, Cho SW, et al. Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: A propensity score-matched analysis. Int J Cardiol 2018;252:1-5. Go to original source... Go to PubMed...
    29. Lim Y, Kim MC, Ahn Y, et al. Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina. J Am Heart Assoc 2022;11:e023776. Go to original source... Go to PubMed...
    30. Weber S, Kahan A, Pailleret JJ, et al. Prevention with molsidomine of coronary artery spasm caused by alkalosis. Am Heart J 1985;109:703-707. Go to original source...
    31. Cattaneo M, Porretta AP, Gallino A. Ranolazine: Drug overview and possible role in primary microvascular angina management. Int J Cardiol 2015;181:376-381. Go to original source... Go to PubMed...
    32. Masumoto A, Mohri M, Shimokawa H, et al. Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina. Circulation 2002;105:1545-1547. Go to original source... Go to PubMed...
    33. Zeppenfeld K, Tfelt-Hansen J, De Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. Go to original source... Go to PubMed...
    34. Sungur MA. Endoscopic Thoracic Sympathectomy in the Treatment of Vasospastic Angina Resistant to Medical Therapy. Anatol J Cardiol 2024;28:29-34. Go to original source... Go to PubMed...
    35. Yoshida K, Inoue T, Hirakawa N, Node K. Endoscopic thoracic sympathectomy as a novel strategy for vasospastic angina refractory to medical treatments. J Cardiol 2008;52:49-52. Go to original source... Go to PubMed...
    36. Abbate A, Hamza M, Cassano AD, et al. Sympathectomy as a treatment for refractory coronary artery spasm. Int J Cardiol 2012;161:e7-e9. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes